Published mark
Amgen
AMGEN INC
NASDAQ: AMGN. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:261db852-46af-4090-af23-91573c948162
- SEC CIK
- 0000318154
- Website
- www.amgen.com Open
- Record version
- vpublic-1:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 3, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Robert A. BradwaySince Feb 13, 2026
- Chair
- Not published
- Independent
- Not published
- Published claims
- 707 distinct sources
- Evidence records
- 280 pinned
- Source conflicts
- 0None open
Built from 7 distinct sources and 28 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
David M. Reese executive of Amgen, effective 2026-02-13.
EffectiveEffective Feb 13, 2026E15
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and Chief Technology Officer | David M. Reese | Feb 2026 | current | Source reportedE15 |
| Senior Vice President, Human Resources | Derek Miller | Feb 2026 | current | Source reportedE16 |
| Executive Vice President, Operations | Esteban Santos | Feb 2026 | current | Source reportedE17 |
| Executive Vice President, Research and Development | James E. Bradner | Feb 2026 | current | Source reportedE18 |
| Executive Vice President, General Counsel and Secretary | Jonathan P. Graham | Feb 2026 | current | Source reportedE19 |
| Executive Vice President, Global Commercial Operations | Michael Gordon | Feb 2026 | current | Source reportedE20 |
| Senior Vice President and Chief Compliance Officer | Nancy A. Grygiel | Feb 2026 | current | Source reportedE22 |
| Executive Vice President and Chief Financial Officer | Peter H. Griffith | Feb 2026 | current | Source reportedE23 |
| Senior Vice President, Business Development | Rachna Khosla | Feb 2026 | current | Source reportedE24 |
| Chairman of the Board, President and Chief Executive Officer | Robert A. Bradway | Feb 2026 | current | Source reportedE25 |
| Executive Vice President, Global Commercial Operations | Murdo Gordon | Not captured | unknown | Source reportedE21 |
Board of directors
Evidence| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Aaron Miles | Independence not published | Not published | AuditAudit; Governance and NominatingGovernance and Nominating | Source reportedE3 |
| Brian J. Druker | Independence not published | Not published | Compensation and Management DevelopmentCompensation and Management Development; Corporate Responsibility and Compliance; ESGCorporate Responsibility and ComplianceESG | Source reportedE4 |
| Charles M. Holley, Jr. | Independence not published | Not published | Audit, chairAudit · Chair; Governance and Nominating; ExecutiveExecutiveGovernance and Nominating | Source reportedE5 |
| Ellen J. Kullman | Independence not published | Not published | Corporate Responsibility and ComplianceESG, chairGovernance and NominatingGovernance and Nominating; Corporate Responsibility and Compliance; ESG · Chair | Source reportedE6 |
| Greg C. Garland | Independence not published | Not published | Compensation and Management DevelopmentExecutiveGovernance and Nominating, chairGovernance and Nominating · Chair; Executive; Compensation and Management Development | Source reportedE7 |
| Mary E. Klotman | Independence not published | Not published | Corporate Responsibility and ComplianceESGGovernance and NominatingGovernance and Nominating; Corporate Responsibility and Compliance; ESG | Source reportedE8 |
| Michael V. Drake | Independence not published | Not published | Corporate Responsibility and ComplianceESGGovernance and NominatingGovernance and Nominating; Corporate Responsibility and Compliance; ESG | Source reportedE9 |
| Robert A. Bradway | Independence not published | Not published | Executive | Source reportedE10 |
| Robert A. Eckert | Independence not published | Not published | Compensation and Management Development, chairExecutiveGovernance and NominatingGovernance and Nominating; Executive; Compensation and Management Development · Chair | Source reportedE11 |
| S. Omar Ishrak | Independence not published | Not published | AuditAudit; Compensation and Management DevelopmentCompensation and Management Development | Source reportedE12 |
| Tyler Jacks | Independence not published | Not published | Compensation and Management DevelopmentCompensation and Management Development; Corporate Responsibility and Compliance; ESGCorporate Responsibility and ComplianceESG | Source reportedE13 |
| Wanda M. Austin | Independence not published | Not published | AuditAudit; Compensation and Management DevelopmentCompensation and Management Development | Source reportedE14 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Charles M. Holley, Jr. | Charles M. Holley, Jr., Aaron Miles, S. Omar Ishrak, Wanda M. Austin | Not described in the published record |
| Audit · Chair; Governance and Nominating; Executive | Not published | Charles M. Holley, Jr. | Not described in the published record |
| Audit; Compensation and Management Development | Not published | S. Omar Ishrak, Wanda M. Austin | Not described in the published record |
| Audit; Governance and Nominating | Not published | Aaron Miles | Not described in the published record |
| Compensation and Management Development | Robert A. Eckert | Robert A. Eckert, Brian J. Druker, Greg C. Garland, S. Omar Ishrak, Tyler Jacks, Wanda M. Austin | Not described in the published record |
| Compensation and Management Development; Corporate Responsibility and Compliance; ESG | Not published | Brian J. Druker, Tyler Jacks | regulatory |
| Corporate Responsibility and Compliance | Not published | Brian J. Druker, Ellen J. Kullman, Mary E. Klotman, Michael V. Drake, Tyler Jacks | regulatory |
| ESG | Ellen J. Kullman | Ellen J. Kullman, Brian J. Druker, Mary E. Klotman, Michael V. Drake, Tyler Jacks | Not described in the published record |
| Executive | Not published | Charles M. Holley, Jr., Greg C. Garland, Robert A. Bradway, Robert A. Eckert | Not described in the published record |
| Governance and Nominating | Greg C. Garland | Greg C. Garland, Aaron Miles, Charles M. Holley, Jr., Ellen J. Kullman, Mary E. Klotman, Michael V. Drake, Robert A. Eckert | Not described in the published record |
| Governance and Nominating · Chair; Executive; Compensation and Management Development | Not published | Greg C. Garland | Not described in the published record |
| Governance and Nominating; Corporate Responsibility and Compliance; ESG | Not published | Mary E. Klotman, Michael V. Drake | regulatory |
| Governance and Nominating; Corporate Responsibility and Compliance; ESG · Chair | Not published | Ellen J. Kullman | regulatory |
| Governance and Nominating; Executive; Compensation and Management Development · Chair | Not published | Robert A. Eckert | Not described in the published record |
Committee RecordAudit: Chair Charles M. Holley, Jr.; Members Charles M. Holley, Jr. (Chair); Aaron Miles; S. Omar Ishrak; Wanda M. Austin
Committee AppointmentCharles M. Holley, Jr.: chair, Audit
Committee AppointmentAaron Miles: member, Audit
Committee AppointmentS. Omar Ishrak: member, Audit
Committee AppointmentWanda M. Austin: member, Audit
Committee RecordCompensation and Management Development: Chair Robert A. Eckert; Members Robert A. Eckert (Chair); Brian J. Druker; Greg C. Garland; S. Omar Ishrak; Tyler Jacks; Wanda M. Austin
Committee AppointmentRobert A. Eckert: chair, Compensation and Management Development
Committee AppointmentBrian J. Druker: member, Compensation and Management Development
Committee AppointmentGreg C. Garland: member, Compensation and Management Development
Committee AppointmentS. Omar Ishrak: member, Compensation and Management Development
Committee AppointmentTyler Jacks: member, Compensation and Management Development
Committee AppointmentWanda M. Austin: member, Compensation and Management Development
Committee RecordCorporate Responsibility and Compliance: Chair not stated; Members Brian J. Druker; Ellen J. Kullman; Mary E. Klotman; Michael V. Drake; Tyler Jacks
Committee AppointmentBrian J. Druker: member, Corporate Responsibility and Compliance
Committee AppointmentEllen J. Kullman: member, Corporate Responsibility and Compliance
Committee AppointmentMary E. Klotman: member, Corporate Responsibility and Compliance
Committee AppointmentMichael V. Drake: member, Corporate Responsibility and Compliance
Committee AppointmentTyler Jacks: member, Corporate Responsibility and Compliance
Committee RecordESG: Chair Ellen J. Kullman; Members Ellen J. Kullman (Chair); Brian J. Druker; Mary E. Klotman; Michael V. Drake; Tyler Jacks
Committee AppointmentEllen J. Kullman: chair, ESG
Committee AppointmentBrian J. Druker: member, ESG
Committee AppointmentMary E. Klotman: member, ESG
Committee AppointmentMichael V. Drake: member, ESG
Committee AppointmentTyler Jacks: member, ESG
Committee RecordExecutive: Chair not stated; Members Charles M. Holley, Jr.; Greg C. Garland; Robert A. Bradway; Robert A. Eckert
Committee AppointmentCharles M. Holley, Jr.: member, Executive
Committee AppointmentGreg C. Garland: member, Executive
Committee AppointmentRobert A. Bradway: member, Executive
Committee AppointmentRobert A. Eckert: member, Executive
Committee RecordGovernance and Nominating: Chair Greg C. Garland; Members Greg C. Garland (Chair); Aaron Miles; Charles M. Holley, Jr.; Ellen J. Kullman; Mary E. Klotman; Michael V. Drake; Robert A. Eckert
Committee AppointmentGreg C. Garland: chair, Governance and Nominating
Committee AppointmentAaron Miles: member, Governance and Nominating
Committee AppointmentCharles M. Holley, Jr.: member, Governance and Nominating
Committee AppointmentEllen J. Kullman: member, Governance and Nominating
Committee AppointmentMary E. Klotman: member, Governance and Nominating
Committee AppointmentMichael V. Drake: member, Governance and Nominating
Committee AppointmentRobert A. Eckert: member, Governance and Nominating
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerRobert A. Bradway, Chairman of the Board, President and Chief Executive Officer, from Feb 13, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Index MembershipNasdaq-100 (NDX)
Security ListingAMGN (NASDAQ)
Index memberships2 memberships attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPXNDX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NASDAQ: AMGN | current | Jan 2, 1992 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
| Nasdaq-100 (Nasdaq) | NASDAQ: AMGN | current | Sep 1, 2026 | exchange verified | Nasdaq official Nasdaq-100 list-type API |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameAMGEN INC
Entity StatusPublic listing published
Official Websitehttps://www.amgen.com
Published FactUS
Published FactDE
Published FactHealthcare
Published Facthttps://www.amgen.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- David M. ReeseExecutive Vice President and Chief Technology Officercompany:261db852-46af-4090-af23-91573c948162:leadership_role:21
- Derek MillerSenior Vice President, Human Resourcescompany:261db852-46af-4090-af23-91573c948162:leadership_role:22
- Esteban SantosExecutive Vice President, Operationscompany:261db852-46af-4090-af23-91573c948162:leadership_role:23
- James E. BradnerExecutive Vice President, Research and Developmentcompany:261db852-46af-4090-af23-91573c948162:leadership_role:24
- Jonathan P. GrahamExecutive Vice President, General Counsel and Secretarycompany:261db852-46af-4090-af23-91573c948162:leadership_role:25
- Michael GordonExecutive Vice President, Global Commercial Operationscompany:261db852-46af-4090-af23-91573c948162:leadership_role:26
- Nancy A. GrygielSenior Vice President and Chief Compliance Officercompany:261db852-46af-4090-af23-91573c948162:leadership_role:28
- Peter H. GriffithExecutive Vice President and Chief Financial Officercompany:261db852-46af-4090-af23-91573c948162:leadership_role:29
- Rachna KhoslaSenior Vice President, Business Developmentcompany:261db852-46af-4090-af23-91573c948162:leadership_role:30
- Robert A. BradwayChairman of the Board, President and Chief Executive Officer; Directorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:31, company:261db852-46af-4090-af23-91573c948162:leadership_role:16
- Murdo GordonExecutive Vice President, Global Commercial Operationscompany:261db852-46af-4090-af23-91573c948162:leadership_role:27
- Aaron MilesDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:9
- Brian J. DrukerDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:10
- Charles M. Holley, Jr.Directorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:11
- Ellen J. KullmanDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:12
- Greg C. GarlandDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:13
- Mary E. KlotmanDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:14
- Michael V. DrakeDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:15
- Robert A. EckertDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:17
- S. Omar IshrakDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:18
- Tyler JacksDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:19
- Wanda M. AustinDirectorcompany:261db852-46af-4090-af23-91573c948162:leadership_role:20
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 28 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 6 Claims.
- E2AMGEN INC Form 10-K (filed 2026-02-13). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E4sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E6sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E7sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E8sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E9sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E10sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E11sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E12sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E13sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E14sec filing. Published Apr 9, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E15sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E16sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E17sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E18sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E19sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E20sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E21AMGN executive roster sourcesec filing. Published May 3, 2026. Retrieved May 3, 2026. Cited by 1 Claim.
- E22sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E23sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E24sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E25sec filing. Published Feb 13, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E26board_seats. board seats. Cited by 37 Claims.
- E27Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
- E28Nasdaq official Nasdaq-100 list-type API. index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:ro-d751713988987e9331980363e24189ce
vpublic-1:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- David M. Reese executive of Amgen, effective 2026-02-13.
- Derek Miller executive of Amgen, effective 2026-02-13.
- Esteban Santos executive of Amgen, effective 2026-02-13.
- James E. Bradner executive of Amgen, effective 2026-02-13.
- Jonathan P. Graham executive of Amgen, effective 2026-02-13.
- Michael Gordon executive of Amgen, effective 2026-02-13.
- Nancy A. Grygiel executive of Amgen, effective 2026-02-13.
- Peter H. Griffith executive of Amgen, effective 2026-02-13.
- Rachna Khosla executive of Amgen, effective 2026-02-13.
- Robert A. Bradway executive of Amgen, effective 2026-02-13.